PI
FLGT icon

PEAK6 Investments’s Fulgent Genetics FLGT Stock Holding History

PEAK6 Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,400
Closed -$269K – 3818
2024
Q1 		$269K Sell
12,400
-3,200
-21% -$79.5K ﹤0.01% 2874
2023
Q4 		$451K Sell
15,600
-65,100
-81% -$1.74M ﹤0.01% 2699
2023
Q3 		$2.16M Buy
80,700
+38,800
+93% +$1.32M 0.01% 1278
2023
Q2 		$1.55M Buy
41,900
+32,800
+360% +$1.14M 0.01% 1383
2023
Q1 		$284K Sell
9,100
-26,700
-75% -$859K ﹤0.01% 2849
2022
Q4 		$1.07M Sell
35,800
-7,000
-16% -$250K 0.01% 1862
2022
Q3 		$1.63M Sell
42,800
-91,700
-68% -$4.6M 0.01% 1740
2022
Q2 		$6.6M Buy
134,500
+119,100
+773% +$6.55M 0.01% 1167
2022
Q1 		$961K Sell
15,400
-70,200
-82% -$4.62M ﹤0.01% 2546
2021
Q4 		$8.61M Buy
85,600
+39,500
+86% +$3.47M 0.02% 800
2021
Q3 		$4.15M Sell
46,100
-77,300
-63% -$7.03M 0.01% 1302
2021
Q2 		$11.4M Buy
+123,400
New +$9.85M 0.03% 617

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PEAK6 Investments's FLGT Position: Q2 2024 in Review

PEAK6 Investments sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 103 shares — an estimated $2.23K sold.

PEAK6 Investments first reported a position in FLGT in Q3 2021 and held it in 10 quarters. The position peaked at $1.25M in Q4 2022. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • PEAK6 Investments reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 103 Fulgent Genetics shares in Q2 2024, an estimated $2.23K.
  • PEAK6 Investments first reported a position in Fulgent Genetics in Q3 2021 and held it in 10 quarters.
  • PEAK6 Investments's Fulgent Genetics position peaked at $1.25M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.